Avantor, Inc. · NYSE:AVTR
Avantor — Q1 2026 Earnings Presentation
10 slides from Avantor's earnings presentation, Apr 29, 2026
Slide 1: Q1 2026 Earnings Presentation
Q1 2026 Earnings Earnings Presentation April 29, 2026
Slide 2: Disclaimer
Disclaimer Forward-looking statements Non-GAAP financial measures This presentation contains forward-looking statements within the meaning of Section 27A of To evaluate our performance, we monitor a number of key indicators at the consolidated the Securities Act of 1933 and Section 21E of the Securi
Slide 3: Revival in Action: Key highlights
Revival in Action: Key highlights Evolve go to market strategy Strategically invest in our manufacturing and supply chain • Q1 results exceeded expectations organization • Revival is already having a positive impact Optimize our • Improved execution and performance portfolio • Engaged and motivated
Slide 4: Revival in Action: Talent
Strengthen our Revival in Action: Talent talent and improve accountability Actions taken ~25% Refresh • ~25% of our ~60 leaders have been refreshed since launch of Revival • More high-impact leaders to come • Self-funded with productivity; year to date headcount -2% Key roles filled • Chief Operatin
Slide 5: Revival in Action: Operations
Strategically invest in our manufacturing Revival in Action: Operations and supply chain organization Revival Activities Case Study: North American Manufacturing Facility Before: People-intensive process Targeted benefits • 8 weeks of Kaizen events in Q1 • Decrease cycle time per unit from >250 • Ca
Slide 6: Q1'26 financial results
Q1’26 financial results Q1’26 Q1’25 Reported revenue $1,581M $1,581M Organic growth -4% -2% Adj. gross profit $501M $535M % of revenues 31.7% 33.8% Adj. EBITDA $219M $270M % of revenues 13.9% 17.0% Adj. operating income $191M $243M % of revenues 12.1% 15.4% Adj. earnings per share $0.17 $0.23 Free c
Slide 7: Q1'26 performance by segment
Q1’26 performance by segment VWR Distribution & Services Bioscience & Medtech Products Reported Adjusted Reported Adjusted Revenue Operating income Revenue Operating income $1,150M $105M $431M $103M Adj. Adj. Organic Growth: -5% Operating 9.2% Organic Growth: -2% Operating 23.8% Margin: Margin: Note
Slide 8: Reaffirmed 2026 guidance
Reaffirmed 2026 guidance1 Guidance Metrics Organic revenue growth -2.5% to -0.5% Adj. EBITDA margin 14.8% to 15.3% Adj. EPS $0.77 to $0.83 Free cash flow2 $500M to $550M 1. Reported revenue range is -1.5% to 0.5%, reflecting 1% FX tailwinds. (FY blended USD / EUR exchange rate of 1.17). 2. Excludes
Slide 9: Summary
Summary • Q1 results exceeded expectations • Revival is already having a positive impact • Improved execution and performance • Engaged and motivated team • We believe that we are turning a corner financially 9
Slide 10: Powering science at every step
Powering science at every step. €\favantor’